ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2025

Abstract Number: 0142

Risk Factors for Antiphospholipid Syndrome-associated Nephropathy: A Retrospective Cohort Analysis

Xiaohan Wei1, Zhixia Yang2, Haoyu Pan2, Yuying Fan2, Jinyi Qian2, Shuyi Yu2 and Hui Shi3, 1Shanghai JiaoTong University, Shanghai, China (People's Republic), 2Department of Rheumatology and Immunology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, Shanghai, Shanghai, China (People's Republic), 3Shanghai Jiaotong University Affiliated Ruijin Hospital, Shanghai, China (People's Republic)

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2025

Keywords: antiphospholipid syndrome, Nephritis, risk factors, Stroke

Session Information

Date: Sunday, October 26, 2025

Title: (0115–0144) Antiphospholipid Syndrome Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: To identify independent clinical and laboratory risk factors associated with antiphospholipid syndrome-associated nephropathy (APSN) and highlight the clinical importance of early screening in high-risk patients.

Methods: This retrospective cohort study included patients with antiphospholipid syndrome (APS) consecutively enrolled in the APS-Shanghai database between January 2021 and March 2025. All patients were classified based on the 2023 ACR/EULAR criteria. Biopsy-confirmed APSN was used as the diagnostic endpoint. Clinical and laboratory data were extracted from the electronic medical record system. Differences between APSN and non-APSN groups were analyzed, and multivariate logistic regression was performed to identify independent risk factors. All statistical analyses were conducted using SPSS version 29.0.

Results: Among 208 APS patients included, 32 (15.4%) were diagnosed with biopsy-confirmed APSN. Compared with patients without renal involvement, those with APSN had a significantly higher prevalence of hypertension, valvular heart disease, thrombocytopenia, ischemic stroke, and cerebrovascular stenosis. Laboratory differences included higher serum creatinine, lower estimated glomerular filtration rate (eGFR), reduced complement C3 levels, and a higher positivity rate for IgA anti-cardiolipin antibodies. Multivariate logistic regression identified three independent clinical predictors of APSN: valvular heart disease (OR = 2.720, 95% CI: 1.049–7.055, P = 0.04), thrombocytopenia (OR = 3.664, 95% CI: 1.601–8.386, P = 0.002), and stroke (OR = 3.948, 95% CI: 1.673–9.313, P = 0.002). These findings suggested that APS patients with these features are at increased risk of developing APSN and may benefit from early screening, including renal function monitoring and consideration for renal biopsy, even in the absence of overt renal symptoms.

Conclusion: This study identified valvular heart disease, thrombocytopenia, and stroke as independent risk factors for APSN. These findings underscore the importance of vigilant renal evaluation in APS patients with systemic vascular involvement and support the role of renal biopsy in clarifying occult nephropathy in high-risk individuals.

Supporting image 1Figure 1. Study flowchart.

Supporting image 2Table 1 Demographic and clinical characteristics at baseline in Antiphospholipid Syndrome (APS) patients

Supporting image 3Table 2 Possible risk factors for developing APSN among APS patients.


Disclosures: X. Wei: None; Z. Yang: None; H. Pan: None; Y. Fan: None; J. Qian: None; S. Yu: None; H. Shi: None.

To cite this abstract in AMA style:

Wei X, Yang Z, Pan H, Fan Y, Qian J, Yu S, Shi H. Risk Factors for Antiphospholipid Syndrome-associated Nephropathy: A Retrospective Cohort Analysis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/risk-factors-for-antiphospholipid-syndrome-associated-nephropathy-a-retrospective-cohort-analysis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-factors-for-antiphospholipid-syndrome-associated-nephropathy-a-retrospective-cohort-analysis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology